Initial Safety of SFM Plus OTOLoc for Creating Side-to-side or End-to-side Colorectal Anastomoses
Part of paid clinical trials in Orlando, Florida.
- Sponsor
- GI Windows, Inc.
- Study ID
- NCT07276529
- Status
- Recruiting
Conditions
- Colorectal Cancer
- Diverticular Diseases
Eligibility Criteria
- Sex
- ALL
- Age
- 22 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Flexagon Self Forming Magnet Anastomosis Plus OTOLoc for Creating side-to-side Colon Anatomoses — DEVICEThe SFM plus OTOLoc is used to create an immediate flow compression anastomosis for patients undergoing: Right or Left Hemicolectomy, Sigmoidectomy and Low Anterior resection
Study Details
The primary objective of this trial is to investigate the safety and effectiveness of the Flexagon 25mm SFM system plus OTOLoc when used to create a side-to-side Ileo-colic, Colo-colonic and side-to-side or end-to-side colorectal anastomoses in participants undergoing colon surgery. This will be evaluated via a composite safety/effectiveness endpoint of patient success defined as successful creation of the target anastomosis without placement procedure, device or target anastomosis related reoperation through 30 days.
Key Dates
- Start date
- Apr 1, 2026
- Status verified
- Apr 2026
- Primary completion
- Jun 30, 2026
- Completion
- Aug 31, 2026
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Flexagon SFM plus OTOLoc for Magnet Colon AnastomosisPatients will receive the Flexagon Self Forming Magnet Anastomosis Plus OTOLoc for Creating side-to-side Ileo-colic, Colo-colonic and side-to-side or end-to-side Colorectal Anastomoses in Patients Undergoing Surgical Procedures via endoscopic or laparoscopic delivery methods
Primary Outcome Measure
Successful anastomosis created with the Flexagon SFM plus OTOLoc without reoperation. [ Time Frame: 30 days ]
Central Contacts
- Peter J Lukin, BS9787610183
- Jessica Musiak, BS617-501-7697
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Orlando Health | Orlando | Florida | 32806 |
Find similar trials in Orlando, FL
By condition
By specialty
By research site
Related Studies
- ColoCare Study - Colorectal Cancer CohortRecruiting · University of Utah · Los Angeles, California
- A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsPHASE1/PHASE2 · Recruiting · Merus B.V. · La Jolla, California
- BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid TumoursPHASE1/PHASE2 · Recruiting · Bold Therapeutics, Inc. · Santa Monica, California
- Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid TumorsPHASE1 · Recruiting · Bicara Therapeutics · La Jolla, California